http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20200032152-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_5069a08ef5b57e309810c2457b0faa53 |
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07B2200-13 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-506 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D471-04 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-506 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D471-04 |
| filingDate | 2018-06-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b67e92b6702a6af85c2e47e712a93283 |
| publicationDate | 2020-03-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | KR-20200032152-A |
| titleOfInvention | Crystalline form and salt form of N-phenyl-2-aminopyrimidine compound, and preparation method thereof |
| abstract | The present invention provides crystalline forms of new N-phenyl-2-aminopyrimidine compounds, crystalline forms of pharmaceutically acceptable salts of the compounds, and methods of making these crystal forms and uses thereof. The present invention also treats pharmaceutical compositions and pharmaceutical preparations comprising crystalline forms of the compounds and pharmaceutically acceptable salts of the compounds, and the use of these crystalline forms, diseases or conditions associated with cellular epidermal growth factor receptor (EGFR). The present invention relates to pharmaceutical compositions and pharmaceutical agents for treating or ameliorating an abnormal cell proliferation state, for example, cancer. |
| priorityDate | 2017-07-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 115.